褚玲丽,荣晗,陈庆翀.肠道微生物在双相障碍发病机制及治疗中的研究进展[J].四川精神卫生杂志,2021,(4):387-392.
肠道微生物在双相障碍发病机制及治疗中的研究进展
Research progress of the role of gut microbiota in the pathogenesis and treatment of bipolar disorder
投稿时间:2021-05-08  
DOI:10.11886/scjsws20210508001
中文关键词:  双相障碍  肠道微生物  益生菌  综述
英文关键词:Bipolar disorder  Gut microbiota  Probiotics  Review
基金项目:
作者单位邮编
褚玲丽 济宁医学院山东 济宁 272067 272067
荣晗 深圳市精神卫生中心广东 深圳 518020 518020
陈庆翀 安徽医科大学安徽 合肥 230032 230032
摘要点击次数:
全文下载次数:
中文摘要:
      本文目的是探讨肠道微生物在双相障碍相关发病机制及治疗中的作用,为双相障碍的诊断和治疗提供新思路。目前双相障碍的发病机制尚不明确,有研究发现肠道微生物可通过多种途径参与双相障碍的发生发展,并有望将肠道微生物作为双相障碍治疗新靶点。本文对近年来关于肠道微生物在双相障碍发病机制及治疗中的研究进展进行综述,为双相障碍进一步研究提供参考。
英文摘要:
      The purpose of this article is to explore the role of gut microbiota in the pathogenesis and treatment of bipolar disorder, so as to provide a new perspective for the clinical diagnosis and treatment of bipolar disorder. The pathogenesis of bipolar disorder remains unclear, while research has identified multiple pathways by which gut microbiota may be involved in the development of bipolar disorder, making it a potential new target for the treatment of bipolar disorder. Therefore, this article reviews recent research advances on the role of gut microbiota in the pathogenesis and treatment of bipolar disorder, thus providing a reference for further research on bipolar disorder.
查看全文  HTML  查看/发表评论  下载PDF阅读器
关闭